Immunotoxin
Showing 101 - 108 of 108
Breast Tumors, Colonic Tumors, Lung Tumors Trial run by the NCI (Rituximab)
Completed
- Breast Neoplasms
- +4 more
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Atopy, Rhinitis, Bronchial Asthma Trial in Hannover (bronchoscopy, allergen/endotoxin instillation)
Terminated
- Atopy
- +2 more
- bronchoscopy, allergen/endotoxin instillation
-
Hannover, GermanyFraunhofer ITEM
Jan 15, 2008
Leukemia, Lymphoma Trial run by the (BL22 immunotoxin, antibody-drug conjugate therapy, immunotoxin therapy)
Suspended
- Leukemia
- Lymphoma
- BL22 immunotoxin
- +3 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Dec 21, 2007
Leukemia, Non-Hodgkin's Lymphoma, NHL Trial in Beverly Hills, Bethesda, Lodz (Immunotoxin therapy, CAT-8015 Immunotoxin,
Unknown status
- Leukemia
- +2 more
- Immunotoxin therapy
- +4 more
-
Beverly Hills, California
- +2 more
Aug 10, 2007
Leukemia Trial in Poland, United States (Immunotoxin therapy, CAT-8015 immunotoxin, Biological therapy)
Unknown status
- Leukemia
- Immunotoxin therapy
- +2 more
-
Beverly Hills, California
- +3 more
Apr 16, 2007
Leukemia, Hairy Cell Leukemia, HCL Trial in Poland, United Kingdom, United States (Immunotoxin therapy, CAT-8015 Immunotoxin,
Unknown status
- Leukemia
- +2 more
- Immunotoxin therapy
- +2 more
-
Stanford, California
- +4 more
Apr 16, 2007
Acute Myeloid Leukemia, Allogeneic Transplantation Trial in Dresden (Gemtuzumab Ozogamicin)
Unknown status
- Acute Myeloid Leukemia
- Allogeneic Transplantation
- Gemtuzumab Ozogamicin
-
Dresden, GermanyMedizinische Klinik und Poliklinik I
Apr 12, 2007
HIV Trial in Stanford (Alvircept sudotox)
Completed
- HIV Infections
- Alvircept sudotox
-
Stanford, CaliforniaStanford Univ Med Ctr
Jun 23, 2005